The Latest Breaking News on Pharma

The pharma industry witnessed solid growth amid the pandemic. Moreover, with surging demand, rising investments in research and development, and increasing e-pharmacy channels, the industry is well-positioned for significant growth over the coming years. Therefore, investors could consider buying fundamentally sound pharma stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and…

Medtronic, the world’s largest medical device company, allegedly "groomed" doctors to overuse its vascular products

US firm Moderna is suing its competitors for alleged patent infringement in relation to their Comirnaty vaccine.

Despite lingering macro disruptions, Street analysts expect pharma stock Pfizer (PFE) to gain double digits in the near term. Moreover, it pays a reliable dividend. Given its robust fundamentals, I think PFE might be an ideal buy for the long haul. Keep reading.

U.S. health advisers are weighing whether the overdose-reversal drug naloxone should be made available as an over-the-counter medication

A decision on a lawsuit in Texas could lead to nationwide mifepristone ban

The Biden administration unveiled three drug payment programs Tuesday aimed at helping reduce patients' out-of-pocket costs.

Move will support growth of flagship product BadgerNet,

CSL has beaten first-half earnings expectations thanks to its vaccine business and contributions from its new iron deficiency therapy company.

Pfizer (PFE) played a pivotal role in developing vaccines and pills that helped the world return to normal from the COVID-19 pandemic. The company reported record revenue and earnings in fiscal 2022. Given the company’s solid growth prospects, it could be wise to invest in the stock right now. Keep…

163% more women would lose access to abortion care if the FDA's approval of mifepristone is revoked.